On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
33° Feels Like: 33°
Wind: NNW 0 mph Past 24 hrs - Precip: 0.31”
Current Radar for Zip

Tonight

Rain/Snow Showers 32°

Tomorrow

Rain/Snow 45°

Sat Night

Partly Cloudy 27°

Alerts

Bayer seeks wider use for eye drug Eylea in Europe

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011.
The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011.

FRANKFURT (Reuters) - German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema.

Bayer has said it expects Eylea, also known as VEGF Trap-Eye, to generate more than 1 billion euros ($1.35 billion) in peak annual sales.

The injection, which Bayer is co-developing with Regeneron, is already approved for other eye diseases. ($1 = 0.7392 euros)

(Reporting by Ludwig Burger; Editing by Christoph Steitz)

Comments